Month: October 2021

Connectomics in Brain Aging and Dementia – The Background and Design of a Study of a Connectome Related to Human Disease

The natural history of Alzheimer’s Disease (AD) includes significant alterations in the human connectome, and this disconnection results in the dementia of AD. The organizing principle of our research project is the idea that the expression of cognitive dysfunction in the elderly is the result of two independent processes — the neuropathology associated with AD, […]

Published on October 8, 2021

Inter- and Intra-Scanner Variability of Automated Brain Volumetry on Three Magnetic Resonance Imaging Systems in Alzheimer’s Disease and Controls

Magnetic Resonance Imaging (MRI) has become part of the clinical routine for diagnosing neurodegenerative disorders. Since acquisitions are performed at multiple centers using multiple imaging systems, detailed analysis of brain volumetry differences between MRI systems and scan-rescan acquisitions can provide valuable information to correct for different MRI scanner effects in multi-center longitudinal studies. To this […]

Published on October 8, 2021

Pfizer COVID Vaccine Less Effective After 2 Months

Two new studies confirm that the immunity offered by two doses of Pfizer’s coronavirus vaccine drops off after about two months, although protection against severe disease, hospitalization and death holds strong. The reports, from Israel and Qatar, add to evidence that… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on October 8, 2021